Challenges in the diagnosis and treatment of candidemia due to multidrug-resistant Candida auris
- PMID: 37746122
- PMCID: PMC10512377
- DOI: 10.3389/ffunb.2023.1061150
Challenges in the diagnosis and treatment of candidemia due to multidrug-resistant Candida auris
Keywords: Candida auris; MDR; candidemia; diagnosis; treatment.
Conflict of interest statement
Outside the submitted work, MB reports research grants and/or personal fees for advisor/consultant and/or speaker/chairman from BioMérieux, Cidara, Gilead, Menarini, MSD, Pfizer, and Shionogi. Outside the submitted work, DG reports investigator-initiated grants from Pfizer, Shionogi, and Gilead Italia, and speaker and/or advisor fees from Pfizer and Tillotts Pharma. Outside the submitted work, AM reports investigator-initiated grant from Gilead Italia. Outside the submitted work, VDP reports research grant from Seegene Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.
Similar articles
-
C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan.Med Mycol. 2021 Dec 3;59(12):1238-1242. doi: 10.1093/mmy/myab057. Med Mycol. 2021. PMID: 34625790
-
Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients.Expert Rev Anti Infect Ther. 2019 Apr;17(4):295-305. doi: 10.1080/14787210.2019.1592675. Epub 2019 Mar 29. Expert Rev Anti Infect Ther. 2019. PMID: 30922129
-
Comparison of risk factors and outcomes of Candida auris candidemia with non-Candida auris candidemia: A retrospective study from Pakistan.Med Mycol. 2020 Aug 1;58(6):721-729. doi: 10.1093/mmy/myz112. Med Mycol. 2020. PMID: 31773169
-
Candida auris-the growing menace to global health.Mycoses. 2019 Aug;62(8):620-637. doi: 10.1111/myc.12904. Epub 2019 Jun 18. Mycoses. 2019. PMID: 30773703 Review.
-
Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen.Microbiologyopen. 2018 Aug;7(4):e00578. doi: 10.1002/mbo3.578. Epub 2018 Jan 18. Microbiologyopen. 2018. PMID: 29345117 Free PMC article.
Cited by
-
Species-Specific Sensitivity and Levels of Beta-D-Glucan for the Diagnosis of Candidemia-A Systematic Review and Meta-Analysis.J Fungi (Basel). 2025 Feb 15;11(2):149. doi: 10.3390/jof11020149. J Fungi (Basel). 2025. PMID: 39997443 Free PMC article. Review.
-
A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin.J Fungi (Basel). 2024 May 20;10(5):362. doi: 10.3390/jof10050362. J Fungi (Basel). 2024. PMID: 38786717 Free PMC article. Review.
References
-
- Al-Obaid I., Asadzadeh M., Ahmad S., Alobaid K., Alfouzan W., Bafna R., et al. (2022). Fatal breakthrough candidemia in an immunocompromised patient in Kuwait due to Candida auris exhibiting reduced susceptibility to echinocandins and carrying a novel mutation in hotspot-1 of FKS1. J. Fungi (Basel) 8 (3), 267. doi: 10.3390/jof8030267 - DOI - PMC - PubMed
-
- Ayala-Gaytan J. J., Montoya A. M., Martinez-Resendez M. F., Guajardo-Lara C. E., de J.T.-R.R., Salazar-Cavazos L., et al. (2021). First case of Candida auris isolated from the bloodstream of a Mexican patient with serious gastrointestinal complications from severe endometriosis. Infection 49 (3), 523–525. doi: 10.1007/s15010-020-01525-1 - DOI - PubMed
LinkOut - more resources
Full Text Sources